INMOBI
12.4.2021 06:02:07 CEST | Business Wire | Press release
stc pay , the leading digital wallet service in Saudi Arabia, won four awards at the MMA SMARTIES MENA 2020 , taking home a silver for COVID-19 Campaign of the Year and a total of three bronze awards in the Mobile App, Lead Generation / Direct Response / Conversions and mCommerce categories. The stc pay 'Stay at Home' campaign was the only campaign the MMA SMARTIES MENA recognized in the mCommerce and COVID-19 App categories in 2020. stc pay was awarded in numerous categories for its ‘Stay at Home’ campaign, which was co-facilitated by UM MENA and InMobi , the world’s leading independent marketing cloud.
To drive adoption of stc pay’s mobile app beginning in March 2020, especially during Eid and Ramadan, stc pay and UM utilized a three-phased approach with InMobi optimizing for specific in-app events during each phase in addition to the overarching objective of growing stc pay’s user base. Phase one of the campaign ran for most of April and highlighted how stc pay helps app users make transfers internationally while at home. Phase two of the campaign ran for the majority of May and used different creatives to highlight the ease of using stc pay from the safety of your home. Phase three was optimized towards gift box transactions, allowing users across Saudi Arabia to send Eidyah to friends and family.
The campaign exceeded the expectations of both stc pay and UM in terms of results, delivering more than 75,000 installs in a span of two months while retaining the overall Cost Per Install (CPI) figures that were well within their benchmarks. InMobi also drove over 103,000 in-app remittances for stc pay across the duration of the campaign and achieved 1.2x more gift box transfers than all other paid channels combined.
“We adapted our brand’s narrative and communication to better suit the pandemic situation during the month of Ramadan. The beauty of digital allows stc pay to act in this agile manner and give consumers what they want and need. Through our partnership with UM and InMobi we were able to effectively deliver this message to consumers and we are thrilled to have the efforts of our campaign recognized by the MMA SMARTIES,” said Abdulkarim Giraud, Digital Marketing Manager at stc pay, KSA.
“Last year was a very atypical year for all of us, requiring even more data driven planning and innovation for new solutions that would cater for rapidly changing consumer behaviors. We thank the MMA and the panel in acknowledging our collective team effort across the four categories,” said Nadeem Ibrahim, Digital Director, KSA at UM.
“2020 was a year unlike anything any of us have ever experienced before, featuring unique challenges that drove us to innovate on new solutions, dig deep into our creative reserves and forge still tighter bonds with our clients. It's quite rewarding to see our close collaboration with agency partners, innovative spirit and creativity be acknowledged by the MMA. We thank the judges and salute the inspiring competition from other brands, agencies and technology providers across the region,” said Andy Powell, VP and Managing Director, EMEA at InMobi.
For more information about the award-winning campaign, go to https://go.inmobi.net/hubfs/InMobi-stc-pay-case-study.pdf and STC Pay Video Case Study .
About stc pay
In harmony with the Kingdom’s Vision 2030 to progress and diversify digital services; stc pay, a subsidiary of stc Group, has been built to become a pioneering service of the futuristic wave that enables new endeavors and unlocks new possibilities.
We share a future vision with customers and businesses to provide new and innovative technologies and digital experiences. Using stc’s powerful network, we are able to better connect merchants with their customers through our secure digital wallet solution, stc pay, to empower both sides to complete their transactions quickly, easily, and securely.
About InMobi
InMobi drives real connections between brands and consumers by leveraging its technology platforms and exclusive access to mobile intelligence. Its Marketing Cloud creates new paths for brands to understand, identify, engage and acquire connected consumers. As a leading technology company, InMobi has been recognized on both the 2018 and 2019 CNBC Disruptor 50 lists and as one of Fast Company’s 2018 World’s Most Innovative Companies. For more information, visit inmobi.com.
About UM MENA
UM is a global media agency committed to Futureproofing our clients’ businesses for the now and the next. We leverage the transformational power of rich business analytics and real-time intelligence to maximize growth and activate the full consumer journey across content and connections. Our consultative approach and agile model, rooted in diversity, equity and belonging, drive better business outcomes for brands.
As the leading global media network owned by IPG Mediabrands and MCN Holding, ranked #1 media agency group in the MENA and #2 globally by RECMA, UM operates in over 100 countries, with more than 5,000 people. UM MENAT has operations in 12 offices and over 400 creative minds in our headquarters in Dubai, innovating on a roster of global and local clients including Coca-Cola, Emirates, Johnson & Johnson, FAB, L’Oreal, McDonalds, Reckitt, Spotify and stc.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210411005021/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
